Co-Diagnostics (NASDAQ:CODX) Continuing to Expand and Evolve to Meet Global Challenges
April 17, 2020 08:30 ET
|
BDA International
New York City, April 17, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics (NASDAQ:CODX) Continuing to Expand and Evolve to Meet Global Challenges Co-Diagnostics (NASDAQ:CODX), with its unique, patented...
Co-Diagnostics (NASDAQ:CODX) Reiterated Buy; Joins Distinguished Group Racing to Meet Unprecedented Global Demand for COVID-19 Testing
March 25, 2020 11:30 ET
|
BDA International
NEW YORK CITY, March 25, 2020 (GLOBE NEWSWIRE) -- The global shortage of COVID-19 testing kits is hitting the United States and other nations hard, but a recent FDA policy change means that...
Buy for Co-Diagnostics (NASDAQ:CODX) Reiterated by H.C. Wainwright with $20 Price Target
March 11, 2020 09:30 ET
|
BDA International
New York City, March 11, 2020 (GLOBE NEWSWIRE) -- Analyst Yi Chen released additional coverage on Co-Diagnostics (NASDAQ:CODX), a Utah-based molecular diagnostics company, raising the firm’s price...
H.C. Wainwright Reiterates Buy on Co-Diagnostics (NASDAQ:CODX) with a $20 PT as Shipments to U.S and Overseas Markets Continue
March 10, 2020 15:11 ET
|
BDA International
NEW YORK CITY, March 10, 2020 (GLOBE NEWSWIRE) -- H.C. Wainwright analyst Yi Chen released additional coverage on Co-Diagnostics (NASDAQ:CODX), a Utah-based molecular diagnostics company, raising...
Co-Diagnostics (NASDAQ:CODX) Ready to Meet U.S Vice President’s Plea for More Domestic Tests
March 06, 2020 13:01 ET
|
BDA International
New York City, March 06, 2020 (GLOBE NEWSWIRE) -- Following US Health and Human Services Secretary Alex Azar declaring a US public health emergency on the potential threat that the novel coronavirus...
Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Risk
February 18, 2020 07:00 ET
|
BDA International
New York City, Feb. 18, 2020 (GLOBE NEWSWIRE) -- As the world continues to worry about the novel coronavirus Covid-19 and investors begin to understand the potential impact this fast-spreading...
Co-Diagnostics (NASDAQ:CODX) Prepares Coronavirus Test as World Health Organization Weighs Global Health Emergency
January 23, 2020 15:05 ET
|
BDA International
New York City, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Shares of Co-Diagnostics, Inc. (Nasdaq:CODX), a biotech company with a patented platform for the development of molecular diagnostic tests, leaped...
Co-Diagnostics (NASDAQ:CODX) CEO Discusses Mosquito Control Test for Deadly EEE Virus
December 19, 2019 07:00 ET
|
BDA International
New York City, Dec. 19, 2019 (GLOBE NEWSWIRE) -- The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of molecular diagnostic tests that has been...
Co-Diagnostics’ (NASDAQ: CODX) Mosquito Control Products Now Includes Test for Deadly EEE Virus
December 11, 2019 07:00 ET
|
BDA International
New York City, Dec. 11, 2019 (GLOBE NEWSWIRE) -- News yesterday from BDA International client Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of molecular...
Co-Diagnostics (NASDAQ:CODX) Gets “Indian FDA” Approval for Infectious Disease Testing in One of the World’s Biggest Markets
December 03, 2019 09:00 ET
|
BDA International
New York City, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech company with a patented platform for the development of molecular diagnostic tests, released what...